Browsing Tag
iStent infinite
1 post
Glaukos at ASCRS 2026: Epioxa commercial launch and the growing case for interventional eye care
Glaukos presents Epioxa and iDose TR data at ASCRS 2026. Full coverage of the keratoconus launch, glaucoma pipeline, Q4 results, and 2026 revenue guidance for NYSE: GKOS.